|
US5866344A
(en)
*
|
1991-11-15 |
1999-02-02 |
Board Of Regents, The University Of Texas System |
Antibody selection methods using cell surface expressed libraries
|
|
US20030036092A1
(en)
*
|
1991-11-15 |
2003-02-20 |
Board Of Regents, The University Of Texas System |
Directed evolution of enzymes and antibodies
|
|
US20060078561A1
(en)
*
|
1994-01-31 |
2006-04-13 |
The Trustees Of Boston University |
Polyclonal antibody libraries
|
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
|
US6696251B1
(en)
*
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
|
RU2233878C2
(ru)
|
1997-01-21 |
2004-08-10 |
Дзе Дженерал Хоспитал Корпорейшн |
Способ отбора желательного белка и нуклеиновой кислоты, средства для его осуществления
|
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
|
WO1998047343A2
(en)
*
|
1997-04-04 |
1998-10-29 |
Biosite Diagnostics, Inc. |
Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
|
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
|
US6555310B1
(en)
|
1997-04-04 |
2003-04-29 |
Biosite Diagnostics, Inc. |
Polyclonal libraries
|
|
AU9796698A
(en)
*
|
1997-10-09 |
1999-05-03 |
Ixsys, Incorporated |
Method for identifying optimal binding ligands to a receptor
|
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US6100063A
(en)
*
|
1998-02-12 |
2000-08-08 |
Novo Nordisk A/S |
Procaryotic cell comprising at least two copies of a gene
|
|
EP1093457B8
(en)
|
1998-03-19 |
2011-02-02 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
|
JP2002510505A
(ja)
|
1998-04-03 |
2002-04-09 |
フィロス インク. |
位置特定可能な蛋白質アレイ
|
|
US6312927B1
(en)
|
1998-08-17 |
2001-11-06 |
Phylos, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation
|
|
PT1105360E
(pt)
|
1998-08-17 |
2009-09-30 |
Bristol Myers Squibb Co |
Identificação de interacções entre compostos-proteínas, utilizando bibliotecas de moléculas de fusão entre proteínas-ácidos nucleicos
|
|
WO2000032823A1
(en)
|
1998-12-02 |
2000-06-08 |
Phylos, Inc. |
Dna-protein fusions and uses thereof
|
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
|
WO2001077137A1
(en)
|
2000-04-12 |
2001-10-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
DE60004025T2
(de)
*
|
1999-03-16 |
2004-06-03 |
Kao Corporation, Chuo-Ku |
Flüssiges deodorant
|
|
WO2000058524A2
(en)
|
1999-03-31 |
2000-10-05 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Typing of human enteroviruses
|
|
EP1187626A4
(en)
|
1999-06-01 |
2006-07-19 |
Compound Therapeutics Inc |
PROCESS FOR THE PREPARATION OF 5'-NUCLEIC ACID PROTEIN CONJUGATES
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
US20040001826A1
(en)
|
1999-06-30 |
2004-01-01 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
US6794132B2
(en)
|
1999-10-02 |
2004-09-21 |
Biosite, Inc. |
Human antibodies
|
|
US20070111259A1
(en)
*
|
1999-10-02 |
2007-05-17 |
Medarex, Inc. |
Human antibodies
|
|
US8071072B2
(en)
|
1999-10-08 |
2011-12-06 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD44
|
|
US6657048B2
(en)
|
1999-10-08 |
2003-12-02 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
US7947496B2
(en)
|
1999-10-08 |
2011-05-24 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD44
|
|
US7442776B2
(en)
|
1999-10-08 |
2008-10-28 |
Young David S F |
Cancerous disease modifying antibodies
|
|
US7419792B2
(en)
|
1999-10-08 |
2008-09-02 |
Arius Research Inc. |
Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
|
|
US8048416B2
(en)
|
1999-10-08 |
2011-11-01 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD44
|
|
US7252821B2
(en)
|
1999-10-08 |
2007-08-07 |
Arius Research Inc. |
Cancerous disease modifying antibodies
|
|
US6680209B1
(en)
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
|
WO2001053539A1
(en)
|
2000-01-24 |
2001-07-26 |
Phylos, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
|
US6835545B2
(en)
*
|
2000-05-08 |
2004-12-28 |
President And Fellows Of Harvard College |
Methods, products and treatments for diabetes
|
|
US7439330B2
(en)
*
|
2000-05-08 |
2008-10-21 |
President And Fellows Of Harvard College |
Anti-glycated CD59 antibodies and uses thereof
|
|
AU6206701A
(en)
*
|
2000-05-26 |
2001-12-03 |
Symphogen As |
Recombinant or purified polyclonal antibodies for treating allergy
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
EP2431054A3
(en)
|
2000-06-15 |
2013-03-06 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
|
KR20060088905A
(ko)
|
2000-06-16 |
2006-08-07 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
면역특이적으로 BLyS에 결합하는 항체
|
|
US6849259B2
(en)
|
2000-06-16 |
2005-02-01 |
Symphogen A/S |
Polyclonal antibody composition for treating allergy
|
|
US6638312B2
(en)
*
|
2000-08-04 |
2003-10-28 |
Depuy Orthopaedics, Inc. |
Reinforced small intestinal submucosa (SIS)
|
|
GB0022978D0
(en)
|
2000-09-19 |
2000-11-01 |
Oxford Glycosciences Uk Ltd |
Detection of peptides
|
|
AU2001226985B8
(en)
*
|
2000-11-08 |
2008-03-13 |
F. Hoffmann-La Roche Ag |
Individualized anti-cancer antibodies
|
|
US20050196755A1
(en)
*
|
2000-11-17 |
2005-09-08 |
Maurice Zauderer |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
EP1340088B1
(en)
*
|
2000-11-17 |
2007-01-17 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
TWI327600B
(en)
|
2000-11-28 |
2010-07-21 |
Medimmune Llc |
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
AU2002220275A1
(en)
*
|
2000-12-08 |
2002-06-18 |
The Board Of Trustees Of The University Of Illinois |
Mutated class ii major histocompatibility proteins
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US20030104402A1
(en)
*
|
2001-01-23 |
2003-06-05 |
University Of Rochester |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
CA2437811A1
(en)
|
2001-02-09 |
2002-08-22 |
Human Genome Sciences, Inc. |
Human g-protein chemokine receptor (ccr5) hdgnr10
|
|
US7129343B2
(en)
*
|
2001-02-13 |
2006-10-31 |
University Of Florida |
Bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
|
|
ES2328796T3
(es)
|
2001-03-14 |
2009-11-18 |
Myriad Genetics, Inc. |
Interaccion tsg101-gag y uso de la misma.
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
DK1385864T3
(da)
|
2001-04-13 |
2010-08-16 |
Human Genome Sciences Inc |
Anti-VEGF-2-antistoffer
|
|
US7064189B2
(en)
|
2001-05-25 |
2006-06-20 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
|
US6867189B2
(en)
|
2001-07-26 |
2005-03-15 |
Genset S.A. |
Use of adipsin/complement factor D in the treatment of metabolic related disorders
|
|
WO2003028625A2
(en)
*
|
2001-08-22 |
2003-04-10 |
Steven Kessler |
Methods for screening monoclonal antibodies on heterogeneous antigen substrates
|
|
US20060073095A1
(en)
*
|
2001-08-22 |
2006-04-06 |
Steven Kessler |
Methods for screening antibody-producing cells on heterogeneous antigen substrates
|
|
AU2002332595A1
(en)
*
|
2001-08-22 |
2003-03-10 |
Steven Kessler |
Methods for screening antibody-producing cells on heterogenous antigen substrates
|
|
US6696271B2
(en)
*
|
2001-08-23 |
2004-02-24 |
The Regents Of The University Of California |
Frozen tissue microarray technology for analysis of RNA, DNA, and proteins
|
|
US20050048566A1
(en)
*
|
2001-08-27 |
2005-03-03 |
Delisi Charles |
Apparatus, composition and method for proteome profiling
|
|
DE60232672D1
(de)
*
|
2001-10-01 |
2009-07-30 |
Dyax Corp |
Mehrkettige eukaryontische display-vektoren und deren verwendungen
|
|
US20040005709A1
(en)
*
|
2001-10-24 |
2004-01-08 |
Hoogenboom Henricus Renerus Jacobus Mattheus |
Hybridization control of sequence variation
|
|
EP2277889B1
(en)
|
2001-12-21 |
2014-07-09 |
Human Genome Sciences, Inc. |
Fusion proteins of albumin and interferon beta
|
|
EP1455819A1
(en)
*
|
2001-12-21 |
2004-09-15 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
EP1757305A3
(en)
*
|
2001-12-21 |
2007-03-14 |
Arius Research, Inc. |
Individualized anti-cancer antibodies
|
|
US7244592B2
(en)
|
2002-03-07 |
2007-07-17 |
Dyax Corp. |
Ligand screening and discovery
|
|
CN1186445C
(zh)
*
|
2002-03-15 |
2005-01-26 |
陈志南 |
抗人肝癌单克隆抗体HAb18轻、重链可变区基因及其应用
|
|
GB0207533D0
(en)
|
2002-04-02 |
2002-05-08 |
Oxford Glycosciences Uk Ltd |
Protein
|
|
US7541150B2
(en)
|
2002-04-08 |
2009-06-02 |
University Of Louisville Research Foundation, Inc |
Method for the diagnosis and prognosis of malignant diseases
|
|
US7357928B2
(en)
|
2002-04-08 |
2008-04-15 |
University Of Louisville Research Foundation, Inc. |
Method for the diagnosis and prognosis of malignant diseases
|
|
US7371383B2
(en)
|
2002-04-12 |
2008-05-13 |
Medimmune, Inc. |
Recombinant anti-interleukin-9 antibodies
|
|
US7012100B1
(en)
*
|
2002-06-04 |
2006-03-14 |
Avolix Pharmaceuticals, Inc. |
Cell migration inhibiting compositions and methods and compositions for treating cancer
|
|
EP1531848A4
(en)
|
2002-06-10 |
2007-03-28 |
Vaccinex Inc |
DIFFERENTIAL EXPRESSED GENE IN BREAST AND BLADDER CANCER AND CODED POLYPEPTIDE
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
CA2489595C
(en)
*
|
2002-06-14 |
2013-05-28 |
Simon E. Hufton |
Recombination of nucleic acid library members
|
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
|
CA2872136C
(en)
|
2002-07-18 |
2017-06-20 |
Merus B.V. |
Recombinant production of mixtures of antibodies
|
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
|
ES2381617T5
(es)
|
2002-08-14 |
2016-02-24 |
Macrogenics, Inc. |
Anticuerpos específicos frente a FcgammaRIIB y sus procedimientos de uso
|
|
MXPA05002934A
(es)
*
|
2002-09-18 |
2006-02-24 |
Univ Pennsylvania |
Composiciones, metodos y kits para deteccion de un antigeno en una celula y en una mezcla biologica.
|
|
DK2891666T3
(en)
|
2002-10-16 |
2017-10-02 |
Purdue Pharma Lp |
Antibodies that bind cell-associated CA 125 / O722P and methods for its use
|
|
US20050147962A1
(en)
*
|
2002-11-19 |
2005-07-07 |
Wagstrom Christopher R. |
Display of dimeric proteins on phage
|
|
DK1583830T3
(da)
*
|
2003-01-07 |
2007-01-15 |
Symphogen As |
Fremgangsmåde til fremstilling af rekombinante polyklonale proteiner
|
|
US20060275766A1
(en)
*
|
2003-01-07 |
2006-12-07 |
Haurum John S |
Method for manufacturing recombinant polyclonal proteins
|
|
CN100383244C
(zh)
*
|
2003-01-07 |
2008-04-23 |
西福根有限公司 |
用于生产重组多克隆蛋白质的方法
|
|
AU2004206250B8
(en)
|
2003-01-21 |
2009-09-17 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
CA2516455C
(en)
|
2003-02-20 |
2012-05-01 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
EA010055B1
(ru)
|
2003-03-19 |
2008-06-30 |
Байоджен Айдек Ма Инк. |
ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА, КОДИРУЮЩАЯ ПОЛИПЕПТИД Sp35, ПОЛИПЕПТИД Sp35 И СПОСОБЫ ПРИМЕНЕНИЯ НУКЛЕИНОВОЙ КИСЛОТЫ И ПОЛИПЕПТИДА
|
|
WO2004091510A2
(en)
|
2003-04-11 |
2004-10-28 |
Medimmune, Inc. |
Recombinant il-9 antibodies and uses thereof
|
|
PL1625166T3
(pl)
|
2003-05-12 |
2015-08-31 |
Helion Biotech Aps |
Przeciwciała przeciwko masp-2
|
|
AU2004242614B2
(en)
|
2003-05-30 |
2011-09-22 |
Merus N.V. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
|
AU2004259727A1
(en)
|
2003-07-15 |
2005-02-03 |
Barros Research Institute |
Compositions and methods for immunotherapy of cancer and infectious diseases.
|
|
CA2445420A1
(en)
|
2003-07-29 |
2005-01-29 |
Invitrogen Corporation |
Kinase and phosphatase assays
|
|
US7619059B2
(en)
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
|
EP2128270B1
(en)
|
2003-08-08 |
2012-10-03 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
|
WO2005042743A2
(en)
|
2003-08-18 |
2005-05-12 |
Medimmune, Inc. |
Humanization of antibodies
|
|
TWI333977B
(en)
|
2003-09-18 |
2010-12-01 |
Symphogen As |
Method for linking sequences of interest
|
|
JP2007518062A
(ja)
*
|
2003-09-29 |
2007-07-05 |
バイオサイト インコーポレイテッド |
敗血症を診断する方法および診断するための組成物
|
|
US20050148029A1
(en)
*
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
|
CA2544920C
(en)
|
2003-11-21 |
2012-09-11 |
Celltech R & D Limited |
Method for the treatment of multiple sclerosis by inhibiting il-17 activity
|
|
AU2004309373A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
GB0329825D0
(en)
|
2003-12-23 |
2004-01-28 |
Celltech R&D Ltd |
Biological products
|
|
ES2646560T3
(es)
|
2004-01-20 |
2017-12-14 |
Merus N.V. |
Mezclas de proteínas de unión
|
|
CA2554089C
(en)
|
2004-02-09 |
2013-10-22 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
WO2005097184A2
(en)
|
2004-03-26 |
2005-10-20 |
Human Genome Sciences, Inc. |
Antibodies against nogo receptor
|
|
US20050260710A1
(en)
*
|
2004-03-31 |
2005-11-24 |
Sekisui Chemical Co. Ltd. |
Methods for producing recombinant polyclonal immunoglobulins
|
|
EP1745149A4
(en)
|
2004-04-15 |
2008-08-06 |
Univ Florida |
NEURALE PROTEINS AS BIOMARKERS FOR INJURY TO THE NERVOUS SYSTEM AND OTHER NEURAL DISORDERS
|
|
CA2562764A1
(en)
|
2004-04-23 |
2005-11-03 |
Richard Kroczek |
Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
|
|
WO2006002437A2
(en)
|
2004-06-24 |
2006-01-05 |
Biogen Idec Ma Inc. |
Treatment of conditions involving demyelination
|
|
US7973134B2
(en)
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
|
EP1967529A1
(en)
*
|
2004-07-20 |
2008-09-10 |
Symphogen A/S |
Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
|
|
DK2053408T3
(da)
|
2004-07-20 |
2012-06-04 |
Symphogen As |
Fremgangsmåde til strukturel karakterisering af et rekombinant polyklonalt protein eller en polyklonal cellelinje
|
|
CN101014245A
(zh)
|
2004-08-03 |
2007-08-08 |
比奥根艾迪克Ma公司 |
神经元功能中的taj
|
|
CA2576195A1
(en)
*
|
2004-08-05 |
2006-02-16 |
Biosite Incorporated |
Compositions and methods for phage display of polypeptides
|
|
CA2580921C
(en)
|
2004-09-21 |
2016-04-12 |
Medimmune, Inc. |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
|
US7935790B2
(en)
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
|
WO2006047417A2
(en)
|
2004-10-21 |
2006-05-04 |
University Of Florida Research Foundation, Inc. |
Detection of cannabinoid receptor biomarkers and uses thereof
|
|
EP1809326A4
(en)
|
2004-10-27 |
2009-11-04 |
Medimmune Inc |
MODULATION OF ANTIBODY SPECIFICITY BY MEASURING ADAPTATION OF ITS AFFINITY TO AN APPARENT ANTIGEN
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
US7807789B2
(en)
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
|
WO2006086098A2
(en)
|
2005-01-06 |
2006-08-17 |
President And Fellows Of Harvard College |
Mass spectrometric methods and products
|
|
CA2599589A1
(en)
|
2005-02-07 |
2006-08-17 |
Genenews,Inc. |
Mild osteoarthritis biomarkers and uses thereof
|
|
KR101289537B1
(ko)
|
2005-02-15 |
2013-07-31 |
듀크 유니버시티 |
항-cd19 항체 및 종양학에서 이의 용도
|
|
US8211430B2
(en)
|
2005-03-04 |
2012-07-03 |
Curedm Group Holdings, Llc |
Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
|
|
WO2006102095A2
(en)
|
2005-03-18 |
2006-09-28 |
Medimmune, Inc. |
Framework-shuffling of antibodies
|
|
US7618809B2
(en)
|
2005-03-23 |
2009-11-17 |
Gebing Ronald A |
Microarrayer with coaxial multiple punches
|
|
EP1707628B1
(en)
*
|
2005-03-30 |
2009-11-11 |
Sekisui Chemical Co., Ltd. |
Methods for producing recombinant polyclonal immunoglobulins
|
|
GB0506912D0
(en)
|
2005-04-05 |
2005-05-11 |
Celltech R&D Ltd |
Biological products
|
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
WO2008157379A2
(en)
|
2007-06-21 |
2008-12-24 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
WO2006113665A2
(en)
|
2005-04-15 |
2006-10-26 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
EP1885755A4
(en)
|
2005-05-05 |
2009-07-29 |
Univ Duke |
CD19 ANTIBODY THERAPY FOR AUTOIMMUNE DISEASES
|
|
EA013821B1
(ru)
|
2005-05-25 |
2010-08-30 |
Кьюрдм, Инк. |
Проостровковые пептиды человека, их производные и аналоги и способы их применения
|
|
US20070110757A1
(en)
|
2005-06-23 |
2007-05-17 |
Ziping Wei |
Antibody formulations having optimized aggregation and fragmentation profiles
|
|
US7482124B2
(en)
|
2005-07-08 |
2009-01-27 |
Bristol-Myers Squibb Company |
Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
|
|
ES2434470T3
(es)
|
2005-07-08 |
2013-12-16 |
Biogen Idec Ma Inc. |
Anticuerpos SP35 y usos de éstos
|
|
JP2009502180A
(ja)
|
2005-08-03 |
2009-01-29 |
アデレイド リサーチ アンド イノベーション ピーティーワイ リミテッド |
多糖シンターゼ
|
|
EP2500358A3
(en)
|
2005-08-19 |
2012-10-17 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
MY169746A
(en)
|
2005-08-19 |
2019-05-14 |
Abbvie Inc |
Dual variable domain immunoglobulin and uses thereof
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
WO2007027906A2
(en)
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
AU2006290567A1
(en)
|
2005-09-14 |
2007-03-22 |
Ucb Pharma S.A |
Comb polymers
|
|
CA2624562A1
(en)
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use
|
|
US8249814B2
(en)
|
2005-10-21 |
2012-08-21 |
Genenews Inc. |
Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
|
|
US20090246189A1
(en)
|
2005-11-04 |
2009-10-01 |
Biogen Idec Ma Inc. And Mclean Hospital |
Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
|
|
EA014900B1
(ru)
|
2005-11-07 |
2011-02-28 |
Зе Скрипс Ресеч Инститьют |
Композиции и способы контроля специфичности передачи сигналов, опосредуемой тканевым фактором
|
|
US20070122413A1
(en)
|
2005-11-28 |
2007-05-31 |
Sivakumar Pallavur V |
Il-21 antagonists
|
|
JP5475994B2
(ja)
|
2005-11-30 |
2014-04-16 |
アッヴィ・インコーポレイテッド |
抗Aβグロブロマー抗体、その抗原結合部分、対応するハイブリドーマ、核酸、ベクター、宿主細胞、前記抗体を作製する方法、前記抗体を含む組成物、前記抗体の使用及び前記抗体を使用する方法。
|
|
KR101439828B1
(ko)
|
2005-11-30 |
2014-09-17 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
|
JP5312039B2
(ja)
|
2005-12-02 |
2013-10-09 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
脱髄の関与する状態の処置
|
|
ZA200804594B
(en)
|
2005-12-09 |
2010-08-25 |
Ucb Pharma Sa |
Antibody molecules having specificity for human IL-6
|
|
US20120208824A1
(en)
|
2006-01-20 |
2012-08-16 |
Cell Signaling Technology, Inc. |
ROS Kinase in Lung Cancer
|
|
PT1981902E
(pt)
|
2006-01-27 |
2015-11-02 |
Biogen Ma Inc |
Antagonistas dos recetores nogo
|
|
EP2540741A1
(en)
|
2006-03-06 |
2013-01-02 |
Aeres Biomedical Limited |
Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
US7504106B2
(en)
*
|
2006-03-14 |
2009-03-17 |
Boris Skurkovich |
Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
|
|
ES2965283T3
(es)
|
2006-03-15 |
2024-05-28 |
Alexion Pharma Inc |
Tratamiento de pacientes con hemoglobinuria paroxística nocturna mediante un inhibidor del complemento
|
|
US20090298093A1
(en)
*
|
2006-04-27 |
2009-12-03 |
Roberto Polakiewicz |
Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
|
|
GB0611116D0
(en)
|
2006-06-06 |
2006-07-19 |
Oxford Genome Sciences Uk Ltd |
Proteins
|
|
MX2008015771A
(es)
|
2006-06-14 |
2009-01-27 |
Macrogenics Inc |
Metodos para el tratamiento de padecimientos autoinmunes usando anticuerpos monoclonales con toxicidad reducida.
|
|
EP2505209A1
(en)
|
2006-06-26 |
2012-10-03 |
MacroGenics, Inc. |
Fcgamma-RIIB-specific antibodies and methods of the use thereof
|
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
|
CA2656347A1
(en)
|
2006-07-03 |
2008-01-10 |
Charles David Adair |
Composition for modulating the expression of cell adhesion molecules
|
|
KR20140072201A
(ko)
|
2006-07-05 |
2014-06-12 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
|
|
WO2008010101A2
(en)
|
2006-07-18 |
2008-01-24 |
Sanofi-Aventis |
Antagonist antibody against epha2 for the treatment of cancer
|
|
US7939636B2
(en)
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
|
EP2064243A2
(en)
|
2006-08-28 |
2009-06-03 |
Kyowa Hakko Kirin Co., Ltd. |
Antagonistic human light-specific human monoclonal antibodies
|
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
MX2009002426A
(es)
|
2006-09-05 |
2009-03-20 |
Alexion Pharma Inc |
Metodos y composiciones para el tratamiento de neuropatias mediadas por anticuerpo.
|
|
CN101512008B
(zh)
|
2006-09-08 |
2015-04-01 |
艾伯维巴哈马有限公司 |
白介素-13结合蛋白
|
|
EP2407548A1
(en)
|
2006-10-16 |
2012-01-18 |
MedImmune, LLC |
Molecules with reduced half-lives, compositions and uses thereof
|
|
GB0620729D0
(en)
|
2006-10-18 |
2006-11-29 |
Ucb Sa |
Biological products
|
|
EP1914242A1
(en)
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Novel anti-CD38 antibodies for the treatment of cancer
|
|
EP2522735A3
(en)
*
|
2006-10-20 |
2013-02-13 |
Arizona Board Of Regents For And On Behalf Arizona State University |
Modified cyanobacteria
|
|
CN101573381A
(zh)
|
2006-11-09 |
2009-11-04 |
Irm责任有限公司 |
激动剂TrkB抗体及其用途
|
|
WO2008064306A2
(en)
|
2006-11-22 |
2008-05-29 |
Curedm, Inc. |
Methods and compositions relating to islet cell neogenesis
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
PT2099823E
(pt)
|
2006-12-01 |
2014-12-22 |
Seattle Genetics Inc |
Agentes de ligação ao alvo variantes e suas utilizações
|
|
EP2687232A1
(en)
|
2006-12-06 |
2014-01-22 |
MedImmune, LLC |
Methods of treating systemic lupus erythematosus
|
|
US8128926B2
(en)
|
2007-01-09 |
2012-03-06 |
Biogen Idec Ma Inc. |
Sp35 antibodies and uses thereof
|
|
SI2740744T1
(en)
|
2007-01-09 |
2018-06-29 |
Biogen Ma Inc. |
Sp35 antibodies and their use
|
|
WO2008101184A2
(en)
|
2007-02-16 |
2008-08-21 |
The Board Of Trustees Of Southern Illinois University |
Arl-1 specific antibodies
|
|
US8685666B2
(en)
|
2007-02-16 |
2014-04-01 |
The Board Of Trustees Of Southern Illinois University |
ARL-1 specific antibodies and uses thereof
|
|
EP2447719B1
(en)
|
2007-02-26 |
2016-08-24 |
Oxford BioTherapeutics Ltd |
Proteins
|
|
WO2008104803A2
(en)
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
|
WO2008104386A2
(en)
|
2007-02-27 |
2008-09-04 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
|
ATE521704T1
(de)
|
2007-03-01 |
2011-09-15 |
Symphogen As |
Verfahren zur klonierung verwandter antikörper
|
|
US20090081659A1
(en)
|
2007-03-07 |
2009-03-26 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
JP5721951B2
(ja)
|
2007-03-22 |
2015-05-20 |
バイオジェン アイデック マサチューセッツ インコーポレイテッド |
抗体、抗体誘導体、および抗体断片を含む、cd154に特異的に結合する結合タンパク質ならびにその使用
|
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
|
CA2682170A1
(en)
|
2007-03-30 |
2008-10-09 |
Medimmune, Llc |
Antibodies with decreased deamidation profiles
|
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
JP5791895B2
(ja)
|
2007-05-04 |
2015-10-07 |
テクノファージ, インベスティガサン エ デセンボルビメント エム ビオテクノロジア,エスエー |
遺伝子操作されたウサギ抗体可変ドメイン及びその使用
|
|
US20080279851A1
(en)
|
2007-05-07 |
2008-11-13 |
Medlmmune, Llc |
Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
CA2685222C
(en)
|
2007-05-14 |
2017-12-19 |
Medimmune, Llc |
Methods of reducing eosinophil levels
|
|
AU2008262384B9
(en)
|
2007-06-05 |
2014-11-27 |
Yale University |
Inhibitors of receptor tyrosine kinases and methods of use thereof
|
|
MY165889A
(en)
|
2007-08-30 |
2018-05-18 |
Curedm Group Holdings Llc |
Compositions and methods of using proislet peptides and analogs thereof
|
|
GB0717337D0
(en)
|
2007-09-06 |
2007-10-17 |
Ucb Pharma Sa |
Method of treatment
|
|
ES2667729T3
(es)
|
2007-09-26 |
2018-05-14 |
Ucb Biopharma Sprl |
Fusiones de anticuerpos con doble especificidad
|
|
ES2576650T3
(es)
|
2007-10-18 |
2016-07-08 |
Cell Signaling Technology, Inc. |
Translocación y ROS quinasa mutante en el carcinoma pulmonar no microcítico humano
|
|
DK2219452T3
(en)
|
2007-11-05 |
2016-01-11 |
Medimmune Llc |
PROCESSES FOR THE TREATMENT OF scleroderma.
|
|
CA2705486C
(en)
|
2007-11-19 |
2019-04-02 |
Celera Corporation |
Lung cancer markers and uses thereof
|
|
EP2062920A3
(en)
|
2007-11-21 |
2009-06-17 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signalling pathways
|
|
US9308257B2
(en)
|
2007-11-28 |
2016-04-12 |
Medimmune, Llc |
Protein formulation
|
|
GB0800277D0
(en)
|
2008-01-08 |
2008-02-13 |
Imagination Tech Ltd |
Video motion compensation
|
|
AU2009203350B2
(en)
|
2008-01-11 |
2014-03-13 |
Gene Techno Science Co., Ltd. |
Humanized anti-alpha9 integrin antibodies and the uses thereof
|
|
BRPI0907046A2
(pt)
|
2008-01-18 |
2015-07-28 |
Medimmune Llc |
Anticorpo de cisteína engenheirada, ácido nucleico isolado, vetor, célula hospedeira, conjugado de anticorpo, composição farmacêutica, métodos de detecção de câncer, doenças ou distúrbios autoimunes, inflamatórios ou infecciosos em um indivíduo e de inibição de proliferação de uma célula alvo
|
|
EP2245052B1
(en)
*
|
2008-01-25 |
2017-05-24 |
Aarhus Universitet |
Selective exosite inhibition of papp-a activity against igfbp-4
|
|
WO2009100309A2
(en)
|
2008-02-08 |
2009-08-13 |
Medimmune, Llc |
Anti-ifnar1 antibodies with reduced fc ligand affinity
|
|
JP6014706B2
(ja)
*
|
2008-02-14 |
2016-10-25 |
株式会社イーベック |
hGM−CSFに結合するモノクローナル抗体および前記抗体を含む医薬組成物
|
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
WO2009118300A1
(en)
|
2008-03-25 |
2009-10-01 |
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Treating cancer by down-regulating frizzled-4 and/or frizzled-1
|
|
CN106349390B
(zh)
|
2008-04-02 |
2019-12-10 |
宏观基因有限公司 |
Bcr-复合体-特异性抗体和其使用方法
|
|
AU2009231991B2
(en)
|
2008-04-02 |
2014-09-25 |
Macrogenics, Inc. |
HER2/neu-specific antibodies and methods of using same
|
|
WO2009126306A2
(en)
|
2008-04-10 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
|
MY159553A
(en)
|
2008-04-11 |
2017-01-13 |
Seattle Genetics Inc |
Detection and treatment of pancreatic, ovarian and other cancers
|
|
GB0807413D0
(en)
|
2008-04-23 |
2008-05-28 |
Ucb Pharma Sa |
Biological products
|
|
US20110117605A1
(en)
*
|
2008-04-23 |
2011-05-19 |
Symphogen A/S |
Methods for Manufacturing a Polyclonal Protein
|
|
CA2721716C
(en)
|
2008-04-24 |
2019-09-24 |
Gene Techno Science Co., Ltd. |
Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
|
|
CN102076355B
(zh)
|
2008-04-29 |
2014-05-07 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
|
EP2282773B2
(en)
|
2008-05-02 |
2025-03-05 |
Seagen Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
CN104558178A
(zh)
|
2008-05-09 |
2015-04-29 |
Abbvie公司 |
针对渐进性糖化终极产物受体(rage)的抗体及其用途
|
|
EP2304439A4
(en)
|
2008-05-29 |
2012-07-04 |
Nuclea Biotechnologies Llc |
ANTI-phospho-AKT ANTIBODY
|
|
TW201008580A
(en)
|
2008-06-03 |
2010-03-01 |
Abbott Lab |
Dual variable domain immunoglobulin and uses thereof
|
|
US9109026B2
(en)
|
2008-06-03 |
2015-08-18 |
Abbvie, Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
EP2282770B1
(en)
|
2008-06-04 |
2018-03-07 |
MacroGenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
|
EP2732823B1
(en)
|
2008-06-25 |
2019-08-07 |
H. Lundbeck A/S |
Modulation of the TrpV : Vps10p-domain receptor system for the treatment of pain
|
|
JP5674654B2
(ja)
|
2008-07-08 |
2015-02-25 |
アッヴィ・インコーポレイテッド |
プロスタグランジンe2二重可変ドメイン免疫グロブリンおよびその使用
|
|
TW201014602A
(en)
|
2008-07-08 |
2010-04-16 |
Abbott Lab |
Prostaglandin E2 binding proteins and uses thereof
|
|
EP2982695B1
(en)
|
2008-07-09 |
2019-04-03 |
Biogen MA Inc. |
Compositions comprising antibodies to lingo or fragments thereof
|
|
US8148088B2
(en)
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
US20100081575A1
(en)
*
|
2008-09-22 |
2010-04-01 |
Robert Anthony Williamson |
Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules
|
|
EP2352760A2
(en)
*
|
2008-09-22 |
2011-08-10 |
Calmune Corporation |
Methods and vectors for display of 2g12-derived domain exchanged antibodies
|
|
AU2009308422B2
(en)
|
2008-10-24 |
2017-01-05 |
The Government of the United States of America as represented by The Secretary, Department of Health and Human Services, Center for Disease Control and Prevention |
Human Ebola virus species and compositions and methods thereof
|
|
US8382203B2
(en)
*
|
2008-11-10 |
2013-02-26 |
Kids Ii, Inc. |
Electromagnetic children's bouncer
|
|
CN102438652B
(zh)
|
2008-11-12 |
2014-08-13 |
米迪缪尼有限公司 |
抗体制剂
|
|
US20110287088A1
(en)
|
2008-12-03 |
2011-11-24 |
Research Development Foundation |
Modulation of olfml-3 mediated angiogenesis
|
|
CN105641694B
(zh)
|
2008-12-19 |
2020-08-14 |
H.隆德贝克有限公司 |
用于治疗精神和行为障碍的对Vps10p-结构域受体家族的调节
|
|
KR20110104032A
(ko)
|
2008-12-19 |
2011-09-21 |
마크로제닉스, 인크. |
공유결합형 디아바디 및 이의 용도
|
|
WO2010078526A1
(en)
|
2008-12-31 |
2010-07-08 |
Biogen Idec Ma Inc. |
Anti-lymphotoxin antibodies
|
|
GB0900425D0
(en)
|
2009-01-12 |
2009-02-11 |
Ucb Pharma Sa |
Biological products
|
|
EP2387584A1
(en)
|
2009-01-14 |
2011-11-23 |
IQ Therapeutics BV |
Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins
|
|
BRPI1007345A2
(pt)
|
2009-01-20 |
2019-04-16 |
H. ZADEH Homayoun |
regeneração óssea de anticorpo mediado
|
|
US20120058131A1
(en)
|
2009-01-21 |
2012-03-08 |
Oxford Biotherapeutics Ltd |
Pta089 protein
|
|
US8852608B2
(en)
|
2009-02-02 |
2014-10-07 |
Medimmune, Llc |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
|
US9364477B2
(en)
|
2009-02-12 |
2016-06-14 |
Cell Signaling Technology, Inc. |
Mutant ROS expression in human cancer
|
|
MX2011008697A
(es)
|
2009-02-17 |
2011-11-18 |
Ucb Pharma Sa |
Moleculas de anticuerpos que tiene especificidad para ox40 humano.
|
|
EP2403531A4
(en)
|
2009-03-05 |
2013-02-27 |
Abbott Lab |
IL-17 BINDING PROTEINS
|
|
WO2010100247A1
(en)
|
2009-03-06 |
2010-09-10 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Novel therapy for anxiety
|
|
CA2754591C
(en)
|
2009-03-10 |
2018-03-06 |
Gene Techno Science Co., Ltd. |
Generation, expression and characterization of the humanized k33n monoclonal antibody
|
|
GB0904214D0
(en)
|
2009-03-11 |
2009-04-22 |
Ucb Pharma Sa |
Biological products
|
|
WO2010112034A2
(en)
|
2009-04-02 |
2010-10-07 |
Aarhus Universitet |
Compositions and methods for treatment and diagnosis of synucleinopathies
|
|
EP2241323A1
(en)
|
2009-04-14 |
2010-10-20 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Tenascin-W and brain cancers
|
|
SG10201401604VA
(en)
|
2009-04-20 |
2014-08-28 |
Oxford Biotherapeutics Ltd |
Antibodies Specific To Cadherin-17
|
|
AU2010270979B2
(en)
|
2009-06-22 |
2015-04-23 |
Medimmune, Llc |
Engineered Fc regions for site-specific conjugation
|
|
BR112012003064B8
(pt)
|
2009-08-13 |
2021-05-25 |
Crucell Holland Bv |
anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo
|
|
EP2292266A1
(en)
|
2009-08-27 |
2011-03-09 |
Novartis Forschungsstiftung, Zweigniederlassung |
Treating cancer by modulating copine III
|
|
TWI465250B
(zh)
|
2009-08-29 |
2014-12-21 |
Abbvie Inc |
治療用之dll4結合蛋白質
|
|
NZ598929A
(en)
|
2009-09-01 |
2014-05-30 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
|
WO2011030107A1
(en)
|
2009-09-10 |
2011-03-17 |
Ucb Pharma S.A. |
Multivalent antibodies
|
|
WO2011035205A2
(en)
|
2009-09-18 |
2011-03-24 |
Calmune Corporation |
Antibodies against candida, collections thereof and methods of use
|
|
EP2480573A1
(en)
|
2009-09-22 |
2012-08-01 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Treating cancer by modulating mex-3
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
TW201116297A
(en)
|
2009-10-02 |
2011-05-16 |
Sanofi Aventis |
Antibodies that specifically bind to the EphA2 receptor
|
|
US20120231004A1
(en)
|
2009-10-13 |
2012-09-13 |
Oxford Biotherapeutic Ltd. |
Antibodies
|
|
WO2011045352A2
(en)
|
2009-10-15 |
2011-04-21 |
Novartis Forschungsstiftung |
Spleen tyrosine kinase and brain cancers
|
|
BR112012008833A2
(pt)
|
2009-10-15 |
2015-09-08 |
Abbott Lab |
imunoglobulinas de dominio variavel duplo e usos das mesmas
|
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
|
GB0922435D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
Method
|
|
EP2493926B1
(en)
|
2009-10-27 |
2020-03-11 |
UCB Biopharma SRL |
Function modifying nav 1.7 antibodies
|
|
US9234037B2
(en)
|
2009-10-27 |
2016-01-12 |
Ucb Biopharma Sprl |
Method to generate antibodies to ion channels
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US20120213801A1
(en)
|
2009-10-30 |
2012-08-23 |
Ekaterina Gresko |
Phosphorylated Twist1 and cancer
|
|
US8420083B2
(en)
|
2009-10-31 |
2013-04-16 |
Abbvie Inc. |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
|
US20120282177A1
(en)
|
2009-11-02 |
2012-11-08 |
Christian Rohlff |
ROR1 as Therapeutic and Diagnostic Target
|
|
WO2011054359A2
(en)
|
2009-11-06 |
2011-05-12 |
University Of Copenhagen |
Method for early detection of cancer
|
|
US9244063B2
(en)
|
2009-11-11 |
2016-01-26 |
Gentian As |
Immunoassay for assessing related analytes of different origin
|
|
JP6174320B2
(ja)
|
2009-11-17 |
2017-08-02 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトヌクレオリンに対するヒトモノクローナル抗体
|
|
GB0920127D0
(en)
|
2009-11-17 |
2009-12-30 |
Ucb Pharma Sa |
Antibodies
|
|
GB0920324D0
(en)
|
2009-11-19 |
2010-01-06 |
Ucb Pharma Sa |
Antibodies
|
|
ES2562832T3
(es)
|
2009-12-08 |
2016-03-08 |
Abbvie Deutschland Gmbh & Co Kg |
Anticuerpos monoclonales contra la proteína RGM para su uso en el tratamiento de la degeneración de la capa de fibra nerviosa de la retina
|
|
GB201000467D0
(en)
|
2010-01-12 |
2010-02-24 |
Ucb Pharma Sa |
Antibodies
|
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
|
PL2505654T5
(pl)
|
2010-02-08 |
2020-11-30 |
Regeneron Pharmaceuticals, Inc. |
Mysz ze wspólnym łańcuchem lekkim
|
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
|
EP2542582A4
(en)
|
2010-03-02 |
2013-12-04 |
Abbvie Inc |
THERAPEUTIC PROTEINS LINKING TO DLL4
|
|
WO2011107586A1
(en)
|
2010-03-05 |
2011-09-09 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research, |
Smoc1, tenascin-c and brain cancers
|
|
GB201005064D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
US10472426B2
(en)
|
2010-03-25 |
2019-11-12 |
Ucb Biopharma Sprl |
Disulfide stabilized DVD-Ig molecules
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
WO2011131611A1
(en)
|
2010-04-19 |
2011-10-27 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Modulating xrn1
|
|
EP2380909A1
(en)
|
2010-04-26 |
2011-10-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
PTK-7 protein involved in breast cancer
|
|
PT2563813E
(pt)
|
2010-04-30 |
2015-11-26 |
Alexion Pharma Inc |
Anticorpos anti-c5a e métodos para utilização dos anticorpos
|
|
KR101848225B1
(ko)
|
2010-05-14 |
2018-04-12 |
애브비 인코포레이티드 |
Il-1 결합 단백질
|
|
US20110293629A1
(en)
|
2010-05-14 |
2011-12-01 |
Bastid Jeremy |
Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists
|
|
WO2011154485A1
(en)
|
2010-06-10 |
2011-12-15 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
Treating cancer by modulating mammalian sterile 20-like kinase 3
|
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
US9139642B2
(en)
|
2010-07-09 |
2015-09-22 |
Crucell Holland B.V. |
Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
|
|
ES2667100T3
(es)
|
2010-08-02 |
2018-05-09 |
Macrogenics, Inc. |
Diacuerpos covalentes y sus usos
|
|
PE20131412A1
(es)
|
2010-08-03 |
2014-01-19 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2012019132A2
(en)
|
2010-08-06 |
2012-02-09 |
Cell Signaling Technology, Inc. |
Anaplastic lymphoma kinase in kidney cancer
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
LT3333188T
(lt)
|
2010-08-19 |
2022-06-10 |
Zoetis Belgium S.A. |
Anti-ngf antikūnai ir jų panaudojimas
|
|
GB201014033D0
(en)
|
2010-08-20 |
2010-10-06 |
Ucb Pharma Sa |
Biological products
|
|
WO2012027555A2
(en)
|
2010-08-25 |
2012-03-01 |
President And Fellows Of Harvard College |
Glycated cd59 peptides, their preparation, and uses thereof
|
|
EP2608803A4
(en)
|
2010-08-26 |
2014-01-15 |
Abbvie Inc |
IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
|
|
US20130171159A1
(en)
|
2010-09-10 |
2013-07-04 |
Brian Arthur Hemmings |
Phosphorylated twist1 and metastasis
|
|
WO2012065937A1
(en)
|
2010-11-15 |
2012-05-24 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
Anti-fungal agents
|
|
US20120275996A1
(en)
|
2010-12-21 |
2012-11-01 |
Abbott Laboratories |
IL-1 Binding Proteins
|
|
BR112013015944A2
(pt)
|
2010-12-21 |
2018-06-19 |
Abbvie Inc |
imunoglobulinas de domínio duplo variável il-1 alpha e beta biespecífico e seus usos.
|
|
JP6147670B2
(ja)
|
2010-12-22 |
2017-06-14 |
テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド |
改善された半減期を有する修飾された抗体
|
|
US10208349B2
(en)
|
2011-01-07 |
2019-02-19 |
Ucb Biopharma Sprl |
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
|
|
GB201100282D0
(en)
|
2011-01-07 |
2011-02-23 |
Ucb Pharma Sa |
Biological methods
|
|
CN103384682B
(zh)
|
2011-01-14 |
2017-04-12 |
Ucb医药有限公司 |
结合il‑17a和il‑17f的抗体分子
|
|
US9540443B2
(en)
|
2011-01-26 |
2017-01-10 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies
|
|
PT2699264T
(pt)
|
2011-04-20 |
2018-05-23 |
Medimmune Llc |
Anticorpos e outras moléculas que ligam b7-h1 e pd-1
|
|
WO2012162068A2
(en)
|
2011-05-21 |
2012-11-29 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use for extending serum half-life
|
|
ES2880291T3
(es)
|
2011-06-02 |
2021-11-24 |
Univ Louisville Res Found Inc |
Nanopartículas conjugadas a un agente antinucleolina
|
|
WO2012168259A1
(en)
|
2011-06-06 |
2012-12-13 |
Novartis Forschungsstiftung, Zweigniederlassung |
Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
|
|
WO2012170740A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Biomarker of asbestos exposure and mesothelioma
|
|
WO2012170742A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Treatment and prevention of cancer with hmgb1 antagonists
|
|
KR102111171B1
(ko)
|
2011-06-10 |
2020-05-14 |
메디뮨 엘엘씨 |
항슈도모나스 psl 결합 분자 및 그의 용도
|
|
MY177267A
(en)
|
2011-06-28 |
2020-09-10 |
Berlin Chemie Ag |
Antibodies
|
|
ES2615256T3
(es)
|
2011-06-28 |
2017-06-06 |
Oxford Biotherapeutics Ltd. |
Objetivo terapéutico y de diagnóstico
|
|
HK1198328A1
(zh)
|
2011-07-13 |
2015-04-02 |
Abbvie Inc. |
使用抗il-13抗體治療哮喘的方法和組合物
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
WO2013022782A1
(en)
|
2011-08-05 |
2013-02-14 |
Regeneron Pharmaceuticals, Inc. |
Humanized universal light chain mice
|
|
CA2842971C
(en)
|
2011-08-05 |
2019-11-12 |
Research Development Foundation |
Improved methods and compositions for modulation of olfml3 mediated angiogenesis
|
|
US9676854B2
(en)
|
2011-08-15 |
2017-06-13 |
Medimmune, Llc |
Anti-B7-H4 antibodies and their uses
|
|
US20140234903A1
(en)
|
2011-09-05 |
2014-08-21 |
Eth Zurich |
Biosynthetic gene cluster for the production of peptide/protein analogues
|
|
WO2013034660A1
(en)
|
2011-09-09 |
2013-03-14 |
Medimmune Limited |
Anti-siglec-15 antibodies and uses thereof
|
|
TW201323440A
(zh)
|
2011-10-24 |
2013-06-16 |
Abbvie Inc |
抗骨硬化素(sclerostin)之免疫結合物
|
|
WO2013067060A1
(en)
|
2011-11-01 |
2013-05-10 |
Bionomics, Inc. |
Anti-gpr49 antibodies
|
|
US9221906B2
(en)
|
2011-11-01 |
2015-12-29 |
Bionomics Inc. |
Methods of inhibiting solid tumor growth by administering GPR49 antibodies
|
|
WO2013067055A1
(en)
|
2011-11-01 |
2013-05-10 |
Bionomics, Inc. |
Methods of blocking cancer stem cell growth
|
|
AU2012332590B2
(en)
|
2011-11-01 |
2016-10-20 |
Bionomics, Inc. |
Anti-GPR49 antibodies
|
|
WO2013068431A1
(en)
|
2011-11-08 |
2013-05-16 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute For Biomedical Research |
New treatment for neurodegenerative diseases
|
|
US20140294732A1
(en)
|
2011-11-08 |
2014-10-02 |
Novartis Forschungsstiftung, Zweigniederlassung, Friedrich Miescher Institute |
Early diagnostic of neurodegenerative diseases
|
|
CN103946237B
(zh)
|
2011-11-11 |
2017-04-12 |
Ucb医药有限公司 |
白蛋白结合抗体及其结合片段
|
|
MX356933B
(es)
|
2011-12-14 |
2018-06-20 |
Abbvie Deutschland |
Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
|
|
CN107459576A
(zh)
|
2011-12-14 |
2017-12-12 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
UY34558A
(es)
|
2011-12-30 |
2013-07-31 |
Abbvie Inc |
Proteínas de unión específicas duales dirigidas contra il-13 y/o il-17
|
|
EP2800583A1
(en)
|
2012-01-02 |
2014-11-12 |
Novartis AG |
Cdcp1 and breast cancer
|
|
GB201201332D0
(en)
|
2012-01-26 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
MY194587A
(en)
|
2012-01-27 |
2022-12-05 |
Abbvie Inc |
Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
|
|
AU2013216863B2
(en)
|
2012-02-10 |
2018-09-06 |
Seagen Inc. |
Detection and treatment of CD30+ cancers
|
|
RS56593B1
(sr)
|
2012-02-15 |
2018-02-28 |
Novo Nordisk As |
Antitela koja vezuju i blokiraju aktivirajući receptor eksprimiran na mijeloidnim ćelijama-1 (trem-1)
|
|
LT2814842T
(lt)
|
2012-02-15 |
2018-11-12 |
Novo Nordisk A/S |
Antikūnai, kurie suriša peptidoglikaną atpažįstantį baltymą 1
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
GB201203071D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
|
GB201203051D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
|
WO2013142808A1
(en)
|
2012-03-23 |
2013-09-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pathogenic phlebovirus isolates and compositions and methods of use
|
|
US20150266961A1
(en)
|
2012-03-29 |
2015-09-24 |
Novartis Forschungsstiftung, Zweigniederlassung, Fridrich Miescher Institute |
Inhibition of interleukin-8 and/or its receptor cxcr1 in the treatment of her2/her3-overexpressing breast cancer
|
|
WO2013143026A1
(en)
*
|
2012-03-31 |
2013-10-03 |
Abmart (Shanghai) Co., Ltd |
Peptide and antibody libraries and uses thereof
|
|
WO2013151649A1
(en)
|
2012-04-04 |
2013-10-10 |
Sialix Inc |
Glycan-interacting compounds
|
|
ES2655842T3
(es)
|
2012-04-18 |
2018-02-21 |
Cell Signaling Technology, Inc. |
EGFR y ROS1 en el cáncer
|
|
CN114163530B
(zh)
|
2012-04-20 |
2025-04-29 |
美勒斯公司 |
用于产生免疫球蛋白样分子的方法和手段
|
|
AU2013262934B2
(en)
|
2012-05-14 |
2018-02-01 |
Biogen Ma Inc. |
LINGO-2 antagonists for treatment of conditions involving motor neurons
|
|
WO2013172951A1
(en)
|
2012-05-15 |
2013-11-21 |
Morphotek, Inc. |
Methods for treatment of gastric cancer
|
|
EP2859018B1
(en)
|
2012-06-06 |
2021-09-22 |
Zoetis Services LLC |
Caninized anti-ngf antibodies and methods thereof
|
|
US10048253B2
(en)
|
2012-06-28 |
2018-08-14 |
Ucb Biopharma Sprl |
Method for identifying compounds of therapeutic interest
|
|
US20150218238A1
(en)
|
2012-06-29 |
2015-08-06 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Resear |
Treating diseases by modulating a specific isoform of mkl1
|
|
US20150184154A1
(en)
|
2012-07-05 |
2015-07-02 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Resear |
New treatment for neurodegenerative diseases
|
|
US20150224190A1
(en)
|
2012-07-06 |
2015-08-13 |
Mohamed Bentires-Alj |
Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the IL-8/CXCR interaction
|
|
UY34905A
(es)
|
2012-07-12 |
2014-01-31 |
Abbvie Inc |
Proteínas de unión a il-1
|
|
CN102851338A
(zh)
|
2012-07-25 |
2013-01-02 |
苏州康宁杰瑞生物科技有限公司 |
利用电荷排斥作用制备同二聚体蛋白混合物的方法
|
|
GB201213652D0
(en)
|
2012-08-01 |
2012-09-12 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
|
AR092745A1
(es)
|
2012-10-01 |
2015-04-29 |
Univ Pennsylvania |
Composiciones que comprenden un dominio de union anti-fap y metodos para hacer blanco en celulas estromales para el tratamiento del cancer
|
|
EP2906241B1
(en)
|
2012-10-12 |
2020-01-08 |
The Brigham and Women's Hospital, Inc. |
Enhancement of the immune response
|
|
AU2013334583B2
(en)
|
2012-10-24 |
2018-09-13 |
Research Development Foundation |
JAM-C antibodies and methods for treatment of cancer
|
|
KR20190096459A
(ko)
|
2012-11-01 |
2019-08-19 |
애브비 인코포레이티드 |
항-vegf/dll4 이원 가변 도메인 면역글로불린 및 이의 용도
|
|
AU2013363962B2
(en)
|
2012-12-21 |
2016-11-24 |
Amplimmune, Inc. |
Anti-H7CR antibodies
|
|
GB201223276D0
(en)
|
2012-12-21 |
2013-02-06 |
Ucb Pharma Sa |
Antibodies and methods of producing same
|
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
|
AU2013202668B2
(en)
|
2012-12-24 |
2014-12-18 |
Adelaide Research & Innovation Pty Ltd |
Inhibition of cancer growth and metastasis
|
|
GB201302447D0
(en)
|
2013-02-12 |
2013-03-27 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
|
WO2014143343A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv core lipid binding domain monoclonal antibodies
|
|
BR112015023239A8
(pt)
|
2013-03-14 |
2018-04-17 |
Abbott Lab |
ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
|
|
BR112015023355A8
(pt)
|
2013-03-14 |
2018-01-30 |
Abbott Lab |
antígenos recombinantes ns3 de hcv e mutantes dos mesmos para detecção de anticorpos aprimorada.
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
KR20150132864A
(ko)
|
2013-03-15 |
2015-11-26 |
애브비 인코포레이티드 |
항체 약물 접합체(adc) 정제
|
|
BR112015023797A2
(pt)
|
2013-03-15 |
2017-10-24 |
Abbvie Inc |
proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
|
|
TW201945032A
(zh)
|
2013-03-15 |
2019-12-01 |
德商艾伯維德國有限及兩合公司 |
抗-egfr抗體藥物結合物調配物
|
|
PT2981822T
(pt)
|
2013-05-06 |
2020-12-07 |
Scholar Rock Inc |
Composições e métodos para modulação do fator de crescimento
|
|
AU2014268298B2
(en)
|
2013-05-24 |
2019-01-17 |
Medlmmune, Llc |
Anti-B7-H5 antibodies and their uses
|
|
SG11201509982UA
(pt)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
|
WO2014197885A2
(en)
|
2013-06-07 |
2014-12-11 |
Duke University |
Inhibitors of complement factor h
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
WO2015019286A1
(en)
|
2013-08-07 |
2015-02-12 |
Friedrich Miescher Institute For Biomedical Research |
New screening method for the treatment friedreich's ataxia
|
|
CA2921652A1
(en)
|
2013-08-21 |
2015-02-26 |
Manuel A. Riquelme |
Compositions and methods for targeting connexin hemichannels
|
|
EP3041507B1
(en)
|
2013-08-26 |
2021-06-30 |
BioNTech Research and Development, Inc. |
Nucleic acids encoding human antibodies to sialyl-lewis a
|
|
CA3120508A1
(en)
|
2013-10-28 |
2015-05-07 |
Dots Technology Corp. |
Allergen detection
|
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
US9738702B2
(en)
|
2014-03-14 |
2017-08-22 |
Janssen Biotech, Inc. |
Antibodies with improved half-life in ferrets
|
|
KR102846903B1
(ko)
|
2014-03-21 |
2025-08-20 |
리제너론 파마슈티칼스 인코포레이티드 |
단일 도메인 결합 단백질을 생산하는 비-인간 동물
|
|
MX2016012873A
(es)
|
2014-04-04 |
2017-03-07 |
Bionomics Inc |
Anticuerpos humanizados que se unen al receptor 5 acoplado a proteina g que contiene repeticion rica en leucina (lgr5).
|
|
CN106413750B
(zh)
|
2014-05-16 |
2022-04-29 |
免疫医疗有限责任公司 |
具有增强的治疗和诊断特性的带有改变的新生儿Fc受体结合的分子
|
|
SMT202100116T1
(it)
|
2014-05-28 |
2021-05-07 |
Agenus Inc |
Anticorpi anti-gitr e metodi di utilizzo degli stessi
|
|
GB201409558D0
(en)
|
2014-05-29 |
2014-07-16 |
Ucb Biopharma Sprl |
Method
|
|
AU2015271685B2
(en)
|
2014-06-04 |
2021-02-18 |
Biontech Research And Development, Inc. |
Human monoclonal antibodies to ganglioside GD2
|
|
WO2015189816A1
(en)
|
2014-06-13 |
2015-12-17 |
Friedrich Miescher Institute For Biomedical Research |
New treatment against influenza virus
|
|
WO2015198202A1
(en)
|
2014-06-23 |
2015-12-30 |
Friedrich Miescher Institute For Biomedical Research |
Methods for triggering de novo formation of heterochromatin and or epigenetic silencing with small rnas
|
|
GB201411320D0
(en)
|
2014-06-25 |
2014-08-06 |
Ucb Biopharma Sprl |
Antibody construct
|
|
US20170165261A1
(en)
|
2014-07-01 |
2017-06-15 |
Brian Arthur Hemmings |
Combination of a brafv600e inhibitor and mertk inhibitor to treat melanoma
|
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
|
GB201412658D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
GB201412659D0
(en)
|
2014-07-16 |
2014-08-27 |
Ucb Biopharma Sprl |
Molecules
|
|
TN2017000008A1
(en)
|
2014-07-17 |
2018-07-04 |
Novo Nordisk As |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity.
|
|
WO2016014725A1
(en)
|
2014-07-22 |
2016-01-28 |
The University Of Notre Dame Du Lac |
Molecular constructs and uses thereof
|
|
WO2016046768A1
(en)
|
2014-09-24 |
2016-03-31 |
Friedrich Miescher Institute For Biomedical Research |
Lats and breast cancer
|
|
WO2016050867A1
(en)
|
2014-10-01 |
2016-04-07 |
Medimmune Limited |
Antibodies to ticagrelor and methods of use
|
|
JP6863888B2
(ja)
|
2014-10-01 |
2021-04-21 |
メディミューン,エルエルシー |
ポリペプチドをコンジュゲートさせる方法
|
|
ES2941897T3
(es)
|
2014-11-12 |
2023-05-26 |
Seagen Inc |
Compuestos que interaccionan con glicanos y procedimientos de uso
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2016094837A2
(en)
|
2014-12-11 |
2016-06-16 |
Igenica Biotherapeutics, Inc. |
Anti-c10orf54 antibodies and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
EP3237450B1
(en)
|
2014-12-22 |
2021-03-03 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
|
WO2016112270A1
(en)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
|
DE112016001013T5
(de)
|
2015-03-03 |
2017-12-21 |
Kymab Limited |
Antikörper, verwendungen und verfahren
|
|
CA2979702A1
(en)
|
2015-03-19 |
2016-09-22 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
|
CN107530427A
(zh)
|
2015-03-27 |
2018-01-02 |
南加利福尼亚大学 |
针对用于实体肿瘤的治疗的lhr的car t细胞疗法
|
|
GB201506869D0
(en)
|
2015-04-22 |
2015-06-03 |
Ucb Biopharma Sprl |
Method
|
|
GB201506870D0
(en)
|
2015-04-22 |
2015-06-03 |
Ucb Biopharma Sprl |
Method
|
|
AU2016256486B2
(en)
|
2015-04-29 |
2021-09-23 |
University Of South Australia |
Compositions and methods for administering antibodies
|
|
US11136613B2
(en)
|
2015-04-30 |
2021-10-05 |
Board Of Regents, The University Of Texas System |
Antibacterial polypeptide libraries and methods for screening the same
|
|
CA3020885A1
(en)
|
2015-05-05 |
2016-11-10 |
Mohammad Tariq MALIK |
Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agents
|
|
BR112017023829A2
(pt)
|
2015-05-06 |
2018-07-31 |
Janssen Biotech Inc |
agentes de ligação biespecíficos de antígeno de membrana específico da próstata (psma) e usos dos mesmos
|
|
CN115109158A
(zh)
|
2015-05-07 |
2022-09-27 |
阿吉纳斯公司 |
抗ox40抗体及其使用方法
|
|
EP3303390A1
(en)
|
2015-05-27 |
2018-04-11 |
UCB Biopharma SPRL |
Method for the treatment of neurological disease
|
|
PE20180193A1
(es)
|
2015-05-29 |
2018-01-26 |
Abbvie Inc |
Anticuerpos anti-cd40 y sus usos
|
|
DK3303394T3
(da)
|
2015-05-29 |
2020-07-06 |
Agenus Inc |
Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
|
|
WO2016197064A1
(en)
|
2015-06-04 |
2016-12-08 |
Epstein Alan L |
Lym-1 and lym-2 targeted car cell immunotherapy
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
|
GB201510758D0
(en)
|
2015-06-18 |
2015-08-05 |
Ucb Biopharma Sprl |
Novel TNFa structure for use in therapy
|
|
GB201601077D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibody molecule
|
|
GB201601075D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies molecules
|
|
GB201601073D0
(en)
|
2016-01-20 |
2016-03-02 |
Ucb Biopharma Sprl |
Antibodies
|
|
WO2017040790A1
(en)
|
2015-09-01 |
2017-03-09 |
Agenus Inc. |
Anti-pd-1 antibodies and methods of use thereof
|
|
AU2016326721C1
(en)
|
2015-09-23 |
2021-06-03 |
Cytoimmune Therapeutics, Inc. |
FLT3 directed car cells for immunotherapy
|
|
SG11201802887PA
(en)
|
2015-10-27 |
2018-05-30 |
Ucb Biopharma Sprl |
Methods of treatment using anti-il-17a/f antibodies
|
|
EP3368566A1
(en)
|
2015-10-28 |
2018-09-05 |
Friedrich Miescher Institute for Biomedical Research |
Tenascin-w and biliary tract cancers
|
|
SG11201803213XA
(en)
|
2015-11-12 |
2018-05-30 |
Siamab Therapeutics Inc |
Glycan-interacting compounds and methods of use
|
|
JP7227007B2
(ja)
|
2015-12-02 |
2023-02-21 |
ストサイエンシス, インコーポレイテッド |
グリコシル化btla(b-及びt-リンパ球減弱因子)に特異的な抗体
|
|
EP3909983A1
(en)
|
2015-12-02 |
2021-11-17 |
STCube & Co. Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
|
GB201521382D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521383D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl And Ucb Celltech |
Method
|
|
GB201521391D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201521389D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Method
|
|
GB201521393D0
(en)
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
EP3386542B1
(en)
|
2015-12-10 |
2020-11-18 |
Katholieke Universiteit Leuven |
Anti adamts13 antibodies and their use for treatment or prevention of haemorrhagic disorders due to ventricular assist device
|
|
BR112018015259A2
(pt)
|
2016-01-27 |
2018-12-18 |
Medimmune Llc |
métodos para preparação de anticorpos com um padrão de glicosilação definido
|
|
GB201602413D0
(en)
|
2016-02-10 |
2016-03-23 |
Nascient Ltd |
Method
|
|
US10889637B2
(en)
|
2016-02-26 |
2021-01-12 |
The Board Of Regents Of The University Of Texas System |
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
|
|
CA3017197A1
(en)
|
2016-03-10 |
2017-09-14 |
Viela Bio, Inc. |
Ilt7 binding molecules and methods of using the same
|
|
US10745487B2
(en)
|
2016-03-22 |
2020-08-18 |
Bionomics Limited |
Method of treating cancer by administering an anti-LGR5 monoclonal antibody
|
|
CN109195991B
(zh)
|
2016-03-29 |
2023-10-31 |
斯特库比股份有限公司 |
对糖基化pd-l1特异的双重功能抗体及其使用方法
|
|
CN109195990A
(zh)
|
2016-03-30 |
2019-01-11 |
Musc研究发展基金会 |
通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
|
|
CN109415441B
(zh)
|
2016-05-24 |
2023-04-07 |
英斯梅德股份有限公司 |
抗体及其制备方法
|
|
CA3024508A1
(en)
|
2016-05-27 |
2017-11-30 |
Agenus Inc. |
Anti-tim-3 antibodies and methods of use thereof
|
|
SG11201810509PA
(en)
|
2016-06-20 |
2018-12-28 |
Kymab Ltd |
Anti-pd-l1 antibodies
|
|
CA3030099A1
(en)
|
2016-07-08 |
2018-01-11 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
|
US11746152B2
(en)
|
2016-07-20 |
2023-09-05 |
Stcube, Inc. |
Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1
|
|
US20200148750A1
(en)
|
2016-07-21 |
2020-05-14 |
Emory University |
Ebola Virus Antibodies and Binding Agents Derived Therefrom
|
|
GB201616596D0
(en)
|
2016-09-29 |
2016-11-16 |
Nascient Limited |
Epitope and antibodies
|
|
JP2019535015A
(ja)
|
2016-10-03 |
2019-12-05 |
アボット・ラボラトリーズAbbott Laboratories |
患者サンプルにおけるgfap状況を評価する改善された方法
|
|
TWI773694B
(zh)
|
2016-10-11 |
2022-08-11 |
美商艾吉納斯公司 |
抗lag-3抗體及其使用方法
|
|
JP2020500214A
(ja)
|
2016-11-02 |
2020-01-09 |
イミュノジェン・インコーポレーテッド |
抗体薬物複合体とparp阻害剤との併用治療
|
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
|
AU2017353939B2
(en)
|
2016-11-07 |
2025-01-30 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
|
|
EP3541847A4
(en)
|
2016-11-17 |
2020-07-08 |
Seattle Genetics, Inc. |
COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
|
|
MA50948A
(fr)
|
2016-12-07 |
2020-10-14 |
Agenus Inc |
Anticorps et procédés d'utilisation de ceux-ci
|
|
AU2017373944B2
(en)
|
2016-12-07 |
2022-02-03 |
Agenus Inc. |
Anti-CTLA-4 antibodies and methods of use thereof
|
|
GB201621635D0
(en)
|
2016-12-19 |
2017-02-01 |
Ucb Biopharma Sprl |
Crystal structure
|
|
MX2019010202A
(es)
|
2017-03-03 |
2019-10-02 |
Seattle Genetics Inc |
Compuestos que interactuan con glicano y metodos de uso.
|
|
CA3261113A1
(en)
|
2017-03-23 |
2025-10-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
|
JP7297672B2
(ja)
|
2017-04-13 |
2023-06-26 |
アジェナス インコーポレイテッド |
抗cd137抗体およびその使用方法
|
|
WO2018191531A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
|
JP2020517242A
(ja)
|
2017-04-21 |
2020-06-18 |
スターテン・バイオテクノロジー・ベー・フェー |
抗ApoC3抗体およびその使用方法
|
|
EP3635407B1
(en)
|
2017-04-28 |
2025-09-10 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
|
WO2018204363A1
(en)
|
2017-05-01 |
2018-11-08 |
Agenus Inc. |
Anti-tigit antibodies and methods of use thereof
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
|
JP7416625B2
(ja)
|
2017-05-25 |
2024-01-17 |
アボット・ラボラトリーズ |
早期バイオマーカーを使用する、頭部への損傷を負ったヒト対象又は負った可能性があるヒト対象に対して、イメージングを実施するかどうかの決定の一助となるための方法
|
|
AR111963A1
(es)
|
2017-05-26 |
2019-09-04 |
Univ California |
Método y moléculas
|
|
EP3631466A1
(en)
|
2017-05-30 |
2020-04-08 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
|
EP3630835A1
(en)
|
2017-05-31 |
2020-04-08 |
STCube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
|
KR102861670B1
(ko)
|
2017-05-31 |
2025-09-18 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
|
JP2020522562A
(ja)
|
2017-06-06 |
2020-07-30 |
ストキューブ アンド シーオー., インコーポレイテッド |
Btn1a1又はbtn1a1リガンドに結合する抗体及び分子を用いて癌を治療する方法
|
|
GB201709379D0
(en)
|
2017-06-13 |
2017-07-26 |
Univ Leuven Kath |
Humanised ADAMTS13 binding antibodies
|
|
CN111315774B
(zh)
|
2017-06-27 |
2023-12-22 |
纽洛可科学有限公司 |
抗fam19a5抗体及其用途
|
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
|
CA3069438A1
(en)
|
2017-07-11 |
2019-01-17 |
Compass Therapeutics Llc |
Agonist antibodies that bind human cd137 and uses thereof
|
|
SG11202000027WA
(en)
|
2017-07-14 |
2020-02-27 |
Immatics Biotechnologies Gmbh |
Improved dual specificity polypeptide molecule
|
|
WO2019036605A2
(en)
|
2017-08-17 |
2019-02-21 |
Massachusetts Institute Of Technology |
MULTIPLE SPECIFICITY BINDING AGENTS OF CXC CHEMOKINES AND USES THEREOF
|
|
MA49950A
(fr)
|
2017-08-25 |
2020-07-01 |
Five Prime Therapeutics Inc |
Anticorps anti-b7-h4 et leurs procédés d'utilisation
|
|
DE112018005145T5
(de)
|
2017-09-15 |
2020-07-23 |
The Regents Of The University Of California |
Hemmung von aminoacylase 3 (aa3) bei der behandlung von krebs
|
|
EA202090812A1
(ru)
|
2017-09-22 |
2020-08-07 |
Уси Байолоджикс Аэлэнд Лимитед |
Новые биспецифические полипептидные комплексы
|
|
KR20250029294A
(ko)
|
2017-09-22 |
2025-03-04 |
우시 바이올로직스 아일랜드 리미티드 |
신규한 이중특이적 cd3/cd19 폴리펩티드 복합체
|
|
KR20240017986A
(ko)
|
2017-09-26 |
2024-02-08 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
암 치료를 위한 조성물 및 방법
|
|
US11707522B2
(en)
|
2017-10-13 |
2023-07-25 |
Boehringer Ingelheim International Gmbh |
Human antibodies to Tn antigen
|
|
WO2019089753A2
(en)
|
2017-10-31 |
2019-05-09 |
Compass Therapeutics Llc |
Cd137 antibodies and pd-1 antagonists and uses thereof
|
|
AU2018361957B2
(en)
|
2017-10-31 |
2023-05-25 |
Staten Biotechnology B.V. |
Anti-ApoC3 antibodies and methods of use thereof
|
|
TW201922294A
(zh)
|
2017-10-31 |
2019-06-16 |
美商伊繆諾金公司 |
抗體-藥物結合物與阿糖胞苷之組合治療
|
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
|
US11851497B2
(en)
|
2017-11-20 |
2023-12-26 |
Compass Therapeutics Llc |
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
|
|
EP3717069A1
(en)
|
2017-11-27 |
2020-10-07 |
Purdue Pharma L.P. |
Humanized antibodies targeting human tissue factor
|
|
CA3067055A1
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
|
WO2019113525A2
(en)
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
|
|
GB201802486D0
(en)
|
2018-02-15 |
2018-04-04 |
Ucb Biopharma Sprl |
Methods
|
|
SG11202007821WA
(en)
|
2018-02-21 |
2020-09-29 |
Five Prime Therapeutics Inc |
B7-h4 antibody formulations
|
|
JP2021516051A
(ja)
|
2018-03-02 |
2021-07-01 |
ファイブ プライム セラピューティクス, インコーポレイテッド |
B7−h4抗体及びその使用方法
|
|
KR20200130696A
(ko)
|
2018-03-12 |
2020-11-19 |
조에티스 서비시즈 엘엘씨 |
항-ngf 항체 및 이의 방법
|
|
WO2019178218A1
(en)
|
2018-03-14 |
2019-09-19 |
Memorial Sloan Kettering Cancer Center |
Anti-polysialic acid antibodies and uses thereof
|
|
AU2019235842B2
(en)
|
2018-03-14 |
2022-02-03 |
Surface Oncology, Inc. |
Antibodies that bind CD39 and uses thereof
|
|
EP3768317A4
(en)
|
2018-03-22 |
2021-12-22 |
Surface Oncology, Inc. |
ANTI-IL-27 ANTIBODIES AND USES THEREOF
|
|
AR117566A1
(es)
|
2018-04-02 |
2021-08-18 |
Bristol Myers Squibb Co |
Anticuerpos anti-trem-1 y sus usos
|
|
WO2019200357A1
(en)
|
2018-04-12 |
2019-10-17 |
Surface Oncology, Inc. |
Biomarker for cd47 targeting therapeutics and uses therefor
|
|
WO2019207159A1
(en)
|
2018-04-27 |
2019-10-31 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
CN112119091B
(zh)
|
2018-05-10 |
2025-01-03 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体及其使用方法
|
|
WO2019222130A1
(en)
|
2018-05-15 |
2019-11-21 |
Immunogen, Inc. |
Combination treatment with antibody-drug conjugates and flt3 inhibitors
|
|
JP2021525243A
(ja)
|
2018-05-21 |
2021-09-24 |
コンパス セラピューティクス リミテッド ライアビリティ カンパニー |
Nk細胞による標的細胞の殺傷を増進するための組成物および方法
|
|
WO2019226658A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Multispecific antigen-binding compositions and methods of use
|
|
US12162934B2
(en)
|
2018-06-18 |
2024-12-10 |
UCB Biopharma SRL |
Gremlin-1 antagonist for the prevention and treatment of cancer
|
|
WO2019244107A1
(en)
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
|
WO2020003172A1
(en)
|
2018-06-26 |
2020-01-02 |
Mor Research Applications |
Transthyretin antibodies and uses thereof
|
|
MA53160A
(fr)
|
2018-07-20 |
2021-05-26 |
Pf Medicament |
Récepteur pour vista
|
|
EP3833442A2
(en)
|
2018-08-09 |
2021-06-16 |
Compass Therapeutics LLC |
Antibodies that bind cd277 and uses thereof
|
|
US20210388089A1
(en)
|
2018-08-09 |
2021-12-16 |
Compass Therapeutics Llc |
Antigen binding agents that bind cd277 and uses thereof
|
|
WO2020033925A2
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antibodies that bind cd277 and uses thereof
|
|
US12391957B2
(en)
|
2018-08-17 |
2025-08-19 |
Icahn School Of Medicine At Mount Sinai |
Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease
|
|
CA3114295A1
(en)
|
2018-09-28 |
2020-04-02 |
Kyowa Kirin Co., Ltd. |
Il-36 antibodies and uses thereof
|
|
WO2020070678A2
(en)
|
2018-10-03 |
2020-04-09 |
Staten Biotechnology B.V. |
Antibodies specific for human and cynomolgus apoc3 and methods of use thereof
|
|
GB201817311D0
(en)
|
2018-10-24 |
2018-12-05 |
Ucb Biopharma Sprl |
Antibodies
|
|
GB201817309D0
(en)
|
2018-10-24 |
2018-12-05 |
Ucb Biopharma Sprl |
Antibodies
|
|
BR112021008795A2
(pt)
|
2018-11-13 |
2021-08-31 |
Compass Therapeutics Llc |
Construtos de ligação multiespecíficos contra moléculas de ponto de verificação e seus usos
|
|
WO2020123011A1
(en)
|
2018-12-13 |
2020-06-18 |
Surface Oncology, Inc. |
Anti-il-27 antibodies and uses thereof
|
|
EP3898687A1
(en)
|
2018-12-20 |
2021-10-27 |
Kyowa Kirin Co., Ltd. |
Fn14 antibodies and uses thereof
|
|
CN113195533B
(zh)
|
2019-01-02 |
2024-04-26 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体及其使用方法
|
|
BR112021013571A2
(pt)
|
2019-01-16 |
2021-09-21 |
Compass Therapeutics Llc |
Formulações de anticorpos que se ligam a cd137 humano e usos das mesmas
|
|
GB201900732D0
(en)
|
2019-01-18 |
2019-03-06 |
Ucb Biopharma Sprl |
Antibodies
|
|
CN113874081A
(zh)
|
2019-02-26 |
2021-12-31 |
茵思博纳公司 |
高-亲和力抗-mertk抗体及其用途
|
|
WO2020185763A1
(en)
|
2019-03-11 |
2020-09-17 |
Memorial Sloan Kettering Cancer Center |
Cd22 antibodies and methods of using the same
|
|
EP3947442A2
(en)
|
2019-03-28 |
2022-02-09 |
Danisco US Inc. |
Engineered antibodies
|
|
US20220242962A1
(en)
|
2019-08-12 |
2022-08-04 |
Aptevo Research And Development Llc |
4-1bb and ox40 binding proteins and related compositions and methods, antibodies against 4-1bb, antibodies against ox40
|
|
MX2022002315A
(es)
|
2019-08-30 |
2022-03-25 |
Agenus Inc |
Anticuerpos anti-cd96 y sus metodos de uso.
|
|
JP2022546768A
(ja)
|
2019-09-04 |
2022-11-08 |
ワイ-バイオロジクス・インコーポレイテッド |
抗vsig4抗体または抗原結合フラグメントおよびその使用
|
|
US11655303B2
(en)
|
2019-09-16 |
2023-05-23 |
Surface Oncology, Inc. |
Anti-CD39 antibody compositions and methods
|
|
TW202521984A
(zh)
|
2019-09-25 |
2025-06-01 |
美商表面腫瘤學有限責任公司 |
抗il-27抗體及其用途
|
|
JP2022549504A
(ja)
|
2019-09-26 |
2022-11-25 |
エスティーキューブ アンド カンパニー |
グリコシル化ctla-4に対して特異的な抗体およびその使用方法
|
|
CN114829404B
(zh)
|
2019-10-09 |
2025-09-09 |
斯特库比公司 |
对糖基化的lag3特异的抗体及其使用方法
|
|
US11459389B2
(en)
|
2019-10-24 |
2022-10-04 |
Massachusetts Institute Of Technology |
Monoclonal antibodies that bind human CD161
|
|
GB201917480D0
(en)
|
2019-11-29 |
2020-01-15 |
Univ Oxford Innovation Ltd |
Antibodies
|
|
GB201919062D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Antibody
|
|
GB201919058D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Multi-specific antibodies
|
|
GB201919061D0
(en)
|
2019-12-20 |
2020-02-05 |
Ucb Biopharma Sprl |
Multi-specific antibody
|
|
TWI877278B
(zh)
|
2019-12-30 |
2025-03-21 |
美商思進公司 |
以非海藻糖苷化抗-cd70抗體治療癌症之方法
|
|
WO2021142002A1
(en)
|
2020-01-06 |
2021-07-15 |
Vaccinex, Inc. |
Anti-ccr8 antibodies and uses thereof
|
|
CN115397848A
(zh)
|
2020-02-05 |
2022-11-25 |
拉利玛生物医药公司 |
Tat肽结合蛋白及其用途
|
|
US20230151108A1
(en)
|
2020-02-13 |
2023-05-18 |
UCB Biopharma SRL |
Bispecific antibodies against cd9 and cd137
|
|
EP4103612A1
(en)
|
2020-02-13 |
2022-12-21 |
UCB Biopharma SRL |
Bispecific antibodies against cd9
|
|
US20230125234A1
(en)
|
2020-02-13 |
2023-04-27 |
UCB Biopharma SRL |
Anti cd44-ctla4 bispecific antibodies
|
|
WO2021160267A1
(en)
|
2020-02-13 |
2021-08-19 |
UCB Biopharma SRL |
Bispecific antibodies against cd9 and cd7
|
|
US20230192900A1
(en)
|
2020-02-13 |
2023-06-22 |
UCB Biopharma SRL |
Bispecific antibodies binding hvem and cd9
|
|
US20230106973A1
(en)
|
2020-02-17 |
2023-04-06 |
Board Of Regents, The University Of Texas System |
Methods for expansion of tumor infiltrating lymphocytes and use thereof
|
|
US20230220074A1
(en)
|
2020-02-18 |
2023-07-13 |
Alector Llc |
Pilra antibodies and methods of use thereof
|
|
CN115768465A
(zh)
|
2020-03-06 |
2023-03-07 |
Ona疗法有限公司 |
抗cd36抗体及其治疗癌症的用途
|
|
WO2021183207A1
(en)
|
2020-03-10 |
2021-09-16 |
Massachusetts Institute Of Technology |
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY OF NPM1c-POSITIVE CANCER
|
|
JP2023518849A
(ja)
|
2020-03-26 |
2023-05-08 |
バンダービルト・ユニバーシティ |
重症急性呼吸器症候群コロナウイルス2(SARS-CoV-2)に対するヒトモノクローナル抗体
|
|
WO2021202473A2
(en)
|
2020-03-30 |
2021-10-07 |
Danisco Us Inc |
Engineered antibodies
|
|
WO2021211331A1
(en)
|
2020-04-13 |
2021-10-21 |
Abbott Point Of Care Inc. |
METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
|
|
WO2021231798A1
(en)
|
2020-05-13 |
2021-11-18 |
Disc Medicine, Inc. |
Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
|
|
CA3182150A1
(en)
|
2020-05-17 |
2021-11-25 |
Astrazeneca Uk Limited |
Sars-cov-2 antibodies and methods of selecting and using the same
|
|
BR112023000603A2
(pt)
|
2020-07-20 |
2023-01-31 |
Astrazeneca Uk Ltd |
Proteínas sars-cov-2, anticorpos anti-sars-cov-2 e métodos de uso dos mesmos
|
|
EP4193149A1
(en)
|
2020-08-04 |
2023-06-14 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
|
US11725052B2
(en)
|
2020-08-18 |
2023-08-15 |
Cephalon Llc |
Anti-PAR-2 antibodies and methods of use thereof
|
|
AU2021359092A1
(en)
|
2020-10-15 |
2023-06-01 |
UCB Biopharma SRL |
Binding molecules that multimerise cd45
|
|
WO2022081436A1
(en)
|
2020-10-15 |
2022-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody specific for sars-cov-2 receptor binding domain and therapeutic methods
|
|
WO2022087274A1
(en)
|
2020-10-21 |
2022-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies that neutralize type-i interferon (ifn) activity
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2022119976A1
(en)
|
2020-12-01 |
2022-06-09 |
Aptevo Research And Development Llc |
Heterodimeric psma and cd3-binding bispecific antibodies
|
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
CA3204628A1
(en)
|
2021-01-13 |
2022-07-21 |
John T. POIRIER |
Antibody-pyrrolobenzodiazepine derivative conjugate
|
|
CN117425500A
(zh)
|
2021-01-13 |
2024-01-19 |
纪念斯隆凯特琳癌症中心 |
抗dll3抗体-药物缀合物
|
|
US20240158503A1
(en)
|
2021-03-03 |
2024-05-16 |
Pierre Fabre Medicament |
Anti-vsig4 antibody or antigen binding fragment and uses thereof
|
|
EP4067381A1
(en)
|
2021-04-01 |
2022-10-05 |
Julius-Maximilians-Universität Würzburg |
Novel tnfr2 binding molecules
|
|
MX2023012902A
(es)
|
2021-05-05 |
2023-11-08 |
Immatics Biotechnologies Gmbh |
Proteinas de union a antigenos que se unen especificamente a prame.
|
|
KR20240005809A
(ko)
|
2021-05-07 |
2024-01-12 |
서피스 온콜로지, 엘엘씨 |
항-il-27 항체 및 이의 용도
|
|
CA3216320A1
(en)
|
2021-05-18 |
2022-11-24 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
EP4348263A1
(en)
|
2021-05-28 |
2024-04-10 |
Alexion Pharmaceuticals, Inc. |
Methods for detecting cm-tma biomarkers
|
|
JP2024522213A
(ja)
|
2021-06-14 |
2024-06-11 |
アルジェニクス ビーブイ |
抗il-9抗体及びその使用方法
|
|
WO2022266034A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
EP4362977A1
(en)
|
2021-06-29 |
2024-05-08 |
Seagen Inc. |
Methods of treating cancer with a combination of a nonfucosylated anti-cd70 antibody and a cd47 antagonist
|
|
WO2023285878A1
(en)
|
2021-07-13 |
2023-01-19 |
Aviation-Ophthalmology |
Methods for detecting, treating, and preventing gpr68-mediated ocular diseases, disorders, and conditions
|
|
MX2024001415A
(es)
|
2021-07-30 |
2024-02-27 |
Ona Therapeutics S L |
Anticuerpos anti-cd36 y su uso para tratar el cancer.
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
AU2022339759A1
(en)
|
2021-08-31 |
2024-03-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
EP4177266A1
(en)
|
2021-11-05 |
2023-05-10 |
Katholieke Universiteit Leuven |
Neutralizing anti-sars-cov-2 human antibodies
|
|
AU2022413677A1
(en)
|
2021-12-17 |
2024-06-27 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
|
JP2025507303A
(ja)
|
2022-02-04 |
2025-03-18 |
アボット・ラボラトリーズ |
試料におけるユビキチンカルボキシ末端ヒドロラーゼl1及び/又はグリア原線維性酸性タンパク質の存在を検出する又はその量を測定するためのラテラルフロー方法、アッセイ及びデバイス
|
|
TW202342510A
(zh)
|
2022-02-18 |
2023-11-01 |
英商Rq生物科技有限公司 |
抗體
|
|
WO2023192436A1
(en)
|
2022-03-31 |
2023-10-05 |
Alexion Pharmaceuticals, Inc. |
Singleplex or multiplexed assay for complement markers in fresh biological samples
|
|
GB202205203D0
(en)
|
2022-04-08 |
2022-05-25 |
UCB Biopharma SRL |
Combination with inhibitor
|
|
GB202205200D0
(en)
|
2022-04-08 |
2022-05-25 |
Ucb Biopharma Sprl |
Combination with chemotherapy
|
|
JP2025514858A
(ja)
|
2022-04-29 |
2025-05-09 |
アストラゼネカ・ユーケイ・リミテッド |
SARS-CoV-2抗体、及びその使用方法
|
|
WO2023240124A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Pseudotyped viral particles for targeting tcr-expressing cells
|
|
AU2023298134A1
(en)
|
2022-06-29 |
2024-11-28 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
|
JP2025525530A
(ja)
|
2022-07-15 |
2025-08-05 |
ヤンセン バイオテツク,インコーポレーテツド |
抗原結合可変領域の改善された生物工学による対合のための材料及び方法
|
|
EP4554619A1
(en)
|
2022-07-15 |
2025-05-21 |
Danisco US Inc. |
Methods for producing monoclonal antibodies
|
|
EP4580753A1
(en)
|
2022-08-31 |
2025-07-09 |
Washington University |
Alphavirus antigen binding antibodies and uses thereof
|
|
CA3266222A1
(en)
|
2022-09-01 |
2024-03-07 |
University Of Georgia Research Foundation, Inc. |
COMPOSITIONS AND METHODS OF DIRECTING APOLIPOPROTEIN L1 TO INDUCE MAMMALIAN CELL DEATH
|
|
WO2024054436A1
(en)
|
2022-09-06 |
2024-03-14 |
Alexion Pharmaceuticals, Inc. |
Diagnostic and prognostic biomarker profiles in patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (hsct-tma)
|
|
JP2025532597A
(ja)
|
2022-09-15 |
2025-10-01 |
アボット・ラボラトリーズ |
軽度及び超軽度の外傷性脳損傷を区別するためのバイオマーカー及び方法
|
|
AU2024240129A1
(en)
|
2023-03-17 |
2025-10-09 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024194685A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
WO2024226969A1
(en)
|
2023-04-28 |
2024-10-31 |
Abbott Point Of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
AU2024277678A1
(en)
|
2023-05-25 |
2025-11-27 |
Dispatch Biotherapeutics, Inc. |
Synthetic cancer antigens as targets for treating cancers
|
|
EP4484445A1
(en)
|
2023-06-26 |
2025-01-01 |
Universität zu Köln |
Hcmv neutralizing antibodies
|
|
WO2025072888A2
(en)
|
2023-09-28 |
2025-04-03 |
Novavax, Inc. |
Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19
|
|
WO2025133707A1
(en)
|
2023-12-19 |
2025-06-26 |
Vectory Therapeutics B.V. |
Anti-tdp-43 antibodies and uses thereof
|
|
TW202540204A
(zh)
|
2024-01-26 |
2025-10-16 |
西班牙商阿爾米雷爾有限公司 |
雙特異性分子及使用其的治療方法
|
|
GB202401567D0
(en)
|
2024-02-06 |
2024-03-20 |
St Georges Hospital Medical School |
Treatment of infectious disease
|
|
WO2025171383A2
(en)
|
2024-02-09 |
2025-08-14 |
Dispatch Biotherapeutics, Inc. |
Engineered cancer antigens and related methods and uses
|
|
WO2025171388A1
(en)
|
2024-02-09 |
2025-08-14 |
Dispatch Biotherapeutics, Inc. |
Engineered cancer antigens with modified domains and related methods and uses
|
|
US20250361297A1
(en)
|
2024-03-12 |
2025-11-27 |
Adaptam Therapeutics, S.L. |
Anti- siglec-15 binding molecules and methods of use
|
|
WO2025226603A1
(en)
|
2024-04-22 |
2025-10-30 |
Surface Oncology, LLC |
Methods for treating cancer using anti-ccr8 antibodies
|